Literature DB >> 18395160

Barriers to obesity treatment.

Marina Mauro1, Valerie Taylor, Sean Wharton, Arya M Sharma.   

Abstract

Obesity, one of the most prevalent health problems in the Western world, is a chronic and progressive condition. Therefore, as with other chronic diseases, patients with obesity require lifelong treatment. Long-term efficacy and effectiveness of obesity treatments is notoriously poor. This may in part be attributable to the substantial barriers that undermine long-term obesity management strategies. These can include lack of recognition of obesity as a chronic condition, low socioeconomic status, time constraints, intimate saboteurs, and a wide range of comorbidities including mental health, sleep, chronic pain, musculoskeletal, cardiovascular, respiratory, digestive and endocrine disorders. Furthermore, medications used to treat some of these disorders may further undermine weight-loss efforts. Lack of specific obesity training of health professionals, attitudes and beliefs as well as coverage and availability of obesity treatments can likewise pose important barriers. Health professionals need to take care to identify, acknowledge and address these barriers where possible to increase patient success as well as compliance and adherence with treatments. Failure to do so may further undermine the sense of failure, low self esteem and self efficacy already common among obese individuals. Addressing treatment barriers can save resources and increase the prospect of long-term success.

Entities:  

Mesh:

Year:  2007        PMID: 18395160     DOI: 10.1016/j.ejim.2007.09.011

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  60 in total

1.  Prevention of cardiovascular disease: obesity, diabetes and the metabolic syndrome.

Authors:  Raj S Padwal; Arya M Sharma
Journal:  Can J Cardiol       Date:  2010 Aug-Sep       Impact factor: 5.223

Review 2.  Obesity educational interventions in U.S. medical schools: a systematic review and identified gaps.

Authors:  Mara Z Vitolins; Sonia Crandall; David Miller; Eddie Ip; Gail Marion; John G Spangler
Journal:  Teach Learn Med       Date:  2012       Impact factor: 2.414

3.  Understanding barriers and facilitators to healthy eating and physical activity from patients either before and after knee arthroplasty.

Authors:  Christine A Pellegrini; Gwendolyn Ledford; Rowland W Chang; Kenzie A Cameron
Journal:  Disabil Rehabil       Date:  2017-05-05       Impact factor: 3.033

4.  The Health at Every Size paradigm and obesity: missing empirical evidence may help push the reframing obesity debate forward.

Authors:  Tarra L Penney; Sara F L Kirk
Journal:  Am J Public Health       Date:  2015-03-19       Impact factor: 9.308

Review 5.  Clinical review: modified 5 As: minimal intervention for obesity counseling in primary care.

Authors:  Michael Vallis; Helena Piccinini-Vallis; Arya M Sharma; Yoni Freedhoff
Journal:  Can Fam Physician       Date:  2013-01       Impact factor: 3.275

6.  Resistance training predicts 6-yr body composition change in postmenopausal women.

Authors:  Jennifer W Bea; Ellen C Cussler; Scott B Going; Robert M Blew; Lauve L Metcalfe; Timothy G Lohman
Journal:  Med Sci Sports Exerc       Date:  2010-07       Impact factor: 5.411

7.  Physiotherapists' perceptions of their role in the rehabilitation management of individuals with obesity.

Authors:  Lila You; Gabrielle Sadler; Sujoy Majumdar; Dawn Burnett; Cathy Evans
Journal:  Physiother Can       Date:  2012-04-05       Impact factor: 1.037

Review 8.  Proposal for a Scientifically Correct and Medically Actionable Disease Classification System (ICD) for Obesity.

Authors:  W Timothy Garvey; Jeffrey I Mechanick
Journal:  Obesity (Silver Spring)       Date:  2020-03       Impact factor: 5.002

9.  The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period.

Authors:  Peter Weeke; Charlotte Andersson; Emil L Fosbøl; Bente Brendorp; Lars Køber; Arya M Sharma; Nick Finer; Philip T James; Ian D Caterson; Richard A Rode; Christian Torp-Pedersen
Journal:  BMC Endocr Disord       Date:  2010-02-26       Impact factor: 2.763

10.  Canadian Physicians' Use of Antiobesity Drugs and Their Referral Patterns to Weight Management Programs or Providers: The SOCCER Study.

Authors:  R S Padwal; S Damjanovic; K M Schulze; R Z Lewanczuk; D C W Lau; A M Sharma
Journal:  J Obes       Date:  2010-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.